137 related articles for article (PubMed ID: 37295414)
1. Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis.
Yu J; Kaur R; Ayeni FE; Eslick GD; Edirimanne S
Horm Metab Res; 2023 Jun; 55(6):379-387. PubMed ID: 37295414
[TBL] [Abstract][Full Text] [Related]
2. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
3. Risk of Adverse Cardiovascular Outcomes in Differentiated Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis.
Qiang JK; Alwithenani R; Uleryk E; Ezzat S; Lipscombe LL; Sawka AM
Thyroid; 2023 Feb; 33(2):192-202. PubMed ID: 36074932
[No Abstract] [Full Text] [Related]
4. Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.
Wang LY; Smith AW; Palmer FL; Tuttle RM; Mahrous A; Nixon IJ; Patel SG; Ganly I; Fagin JA; Boucai L
Thyroid; 2015 Mar; 25(3):300-7. PubMed ID: 25386760
[TBL] [Abstract][Full Text] [Related]
5. Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer.
Pajamäki N; Metso S; Hakala T; Ebeling T; Huhtala H; Ryödi E; Sand J; Jukkola-Vuorinen A; Kellokumpu-Lehtinen PL; Jaatinen P
Clin Endocrinol (Oxf); 2018 Feb; 88(2):303-310. PubMed ID: 29154445
[TBL] [Abstract][Full Text] [Related]
6. Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study.
Klein Hesselink EN; Klein Hesselink MS; de Bock GH; Gansevoort RT; Bakker SJ; Vredeveld EJ; van der Horst-Schrivers AN; van der Horst IC; Kamphuisen PW; Plukker JT; Links TP; Lefrandt JD
J Clin Oncol; 2013 Nov; 31(32):4046-53. PubMed ID: 24101052
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis.
Gubbi S; Al-Jundi M; Foerster P; Cardenas S; Butera G; Auh S; Wright EC; Klubo-Gwiezdzinska J
Thyroid; 2024 May; ():. PubMed ID: 38717947
[No Abstract] [Full Text] [Related]
8. The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer.
Zou Y; Li B; Wang X; Mao J; Zhang Y
Medicine (Baltimore); 2022 Dec; 101(48):e31991. PubMed ID: 36482589
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of TSH suppression therapy and the risk of cardiovascular events after thyroid cancer surgery.
Yang X; Guo N; Gao X; Liang J; Fan X; Zhao Y
Front Endocrinol (Lausanne); 2022; 13():991876. PubMed ID: 36619576
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
Lee MC; Kim MJ; Choi HS; Cho SW; Lee GH; Park YJ; Park DJ
Endocrinol Metab (Seoul); 2019 Jun; 34(2):150-157. PubMed ID: 31099202
[TBL] [Abstract][Full Text] [Related]
11. Effect of Thyroid-Stimulating Hormone Suppression Therapy on Cardiac Structure and Function in Patients With Differentiated Thyroid Cancer After Thyroidectomy: A Systematic Review and Meta-Analysis.
Zhang H; Yang Y; Gao C; Tian L
Endocr Pract; 2024 Feb; 30(2):177-186. PubMed ID: 38007181
[TBL] [Abstract][Full Text] [Related]
12. Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis.
Kostopoulos G; Doundoulakis I; Antza C; Bouras E; Nirantharakumar K; Tsiachris D; Thomas GN; Lip GYH; Toulis KA
Endocr Relat Cancer; 2021 Apr; 28(5):325-335. PubMed ID: 33794503
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
Park S; Kim WG; Han M; Jeon MJ; Kwon H; Kim M; Sung TY; Kim TY; Kim WB; Hong SJ; Shong YK
Thyroid; 2017 Sep; 27(9):1164-1170. PubMed ID: 28699428
[TBL] [Abstract][Full Text] [Related]
14. Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer.
Klubo-Gwiezdzinska J; Auh S; Gershengorn M; Daley B; Bikas A; Burman K; Wartofsky L; Urken M; Dewey E; Smallridge R; Chindris AM; Kebebew E
JAMA Netw Open; 2019 Feb; 2(2):e187754. PubMed ID: 30707227
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature.
Parker WA; Edafe O; Balasubramanian SP
Pragmat Obs Res; 2017; 8():57-67. PubMed ID: 28553154
[TBL] [Abstract][Full Text] [Related]
16. Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma.
Klein Hesselink EN; Lefrandt JD; Schuurmans EP; Burgerhof JG; Groen B; Gansevoort RT; van der Horst-Schrivers AN; Dullaart RP; Van Gelder IC; Brouwers AH; Rienstra M; Links TP
J Clin Endocrinol Metab; 2015 Dec; 100(12):4563-9. PubMed ID: 26480284
[TBL] [Abstract][Full Text] [Related]
17. PROGNOSIS OF DIFFERENTIATED THYROID CARCINOMA IN PATIENTS WITH GRAVES DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Mekraksakit P; Rattanawong P; Karnchanasorn R; Kanitsoraphan C; Leelaviwat N; Poonsombudlert K; Kewcharoen J; Dejhansathit S; Samoa R
Endocr Pract; 2019 Dec; 25(12):1323-1337. PubMed ID: 31412224
[No Abstract] [Full Text] [Related]
18. Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
Ku EJ; Yoo WS; Lee EK; Ahn HY; Woo SH; Hong JH; Chung HK; Park JW
J Clin Endocrinol Metab; 2021 Nov; 106(12):3655-3667. PubMed ID: 34302730
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
James DL; Ryan ÉJ; Davey MG; Quinn AJ; Heath DP; Garry SJ; Boland MR; Young O; Lowery AJ; Kerin MJ
JAMA Otolaryngol Head Neck Surg; 2021 Jun; 147(6):544-552. PubMed ID: 33792650
[TBL] [Abstract][Full Text] [Related]
20. Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.
Do Cao C; Wémeau JL
Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S47-52. PubMed ID: 26826483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
